about
BCCIP associates with the receptor protein tyrosine phosphatase PTPmuHypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cellsArginine methyltransferases as novel therapeutic targets for breast cancerE-cadherin and gastric cancer: cause, consequence, and applicationsDepletion of E-cadherin disrupts establishment but not maintenance of cell junctions in Madin-Darby canine kidney epithelial cells.Soluble Neural-cadherin as a novel biomarker for malignant bone and soft tissue tumors.Functional characterization of E- and P-cadherin in invasive breast cancer cells.15-Deoxy-Δ12,14-prostaglandin J2 inhibits migration of human thyroid carcinoma cells by disrupting focal adhesion complex and adherens junction.Expression of E-Cadherin/Beta-Catenin in Epithelial Carcinomas of the Thyroid GlandGenetic screening for familial gastric cancer.Transactivation of MCP-1/CCL2 by beta-catenin/TCF-4 in human breast cancer cells.N-terminal 1-54 amino acid sequence and Armadillo repeat domain are indispensable for P120-catenin isoform 1A in regulating E-cadherin.Inhibitory effects of calcium against intestinal cancer in human colon cancer cells and Apc(Min/+) mice.Negative correlation of LIV-1 and E-cadherin expression in hepatocellular carcinoma cellsAbnormal expression of serum soluble E-cadherin is correlated with clinicopathological features and prognosis of breast cancer.Role of tissue stroma in cancer cell invasion.An association between type Iγ PI4P 5-kinase and Exo70 directs E-cadherin clustering and epithelial polarizationStructure-based models of cadherin-mediated cell adhesion: the evolution continues.A novel role for CD46 in wound repairPrognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma.Relationship between expression of E-cadherin-catenin complex and clinicopathologic characteristics of pancreatic cancer.Expression of β-catenin and REG Iα in relation to cell proliferative ability in salivary gland tumorsVertebrate development requires ARVCF and p120 catenins and their interplay with RhoA and Rac.The E-cadherin-beta-catenin complex and its implication in lung cancer progression and prognosis.Role of calcium and other trace elements in the gastrointestinal physiology.Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells.Upregulation of calcium-sensing receptor and mitogen-activated protein kinase signalling in the regulation of growth and differentiation in colon carcinoma.Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline.Thiazolidinediones: potential as therapeutics for psoriasis and perhaps other hyperproliferative skin disease.Biogenesis and function of mouse mammary epithelium depends on the presence of functional alpha-catenin.Comparison of Clinical and Ultrasonographic Features of Poorly Differentiated Thyroid Carcinoma and Papillary Thyroid CarcinomaCalcium, calcium-sensing receptor and growth control in the colonic mucosa.Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion frontSlit-2 induces a tumor-suppressive effect by regulating beta-catenin in breast cancer cells.Adherens and tight junctions: structure, function and connections to the actin cytoskeleton.Hepatocyte polaritySoluble cadherins as cancer biomarkers.Persisting and Increasing Neutrophil Infiltration Associates with Gastric Carcinogenesis and E-cadherin Downregulation.Calcium-sensing receptor in cancer: good cop or bad cop?Overexpression of RNF146 in non-small cell lung cancer enhances proliferation and invasion of tumors through the Wnt/β-catenin signaling pathway
P2860
Q24656076-DCAD32BD-1D1B-44EA-BECF-86E13C9A65A5Q24685207-C0D0190B-CCC4-44FE-8E62-76DBE60D4996Q26851594-99C8B6CC-66D8-41E9-BF91-B530AF7750F5Q27000278-0B688009-372F-4AE2-97B9-85A0D2860ED5Q30442081-5A9B55E3-FCCD-4D9E-8672-7210DEC435EEQ31121792-97AB4BD1-3E14-4D96-A093-C27F8D5CB1FAQ33414412-BB5E3BE6-A569-4C9B-9822-AC7FE73BAE08Q33597917-2B007B60-82B5-4884-80C3-D62336283269Q33646067-F4901B7B-9265-4C33-ADF0-459409231011Q33732282-2B8CF861-999E-4451-9C8C-7D61196F365BQ34249533-098828EE-5AA9-4D92-A6F4-7C4EBEE0DE2FQ34277606-905263EA-6DBA-42E8-8AC2-B80BA1DEBC4CQ34496450-91F2C6BA-A112-490D-9B60-72B1FB386060Q34598899-F18C74AF-1C36-49C7-8D5D-AADDF7526500Q34789523-86D485B9-D559-4EA8-9886-63B6A8911195Q35170428-9DDA54C1-55CF-4CAD-B401-07F03E62B50EQ35642916-5C073A9D-5442-4F8B-B7D4-0E610F81F0CEQ35854120-F4E8D88E-881D-4087-B145-5BE458D05AC4Q35928410-B5E05ED6-5D20-401F-A13A-13158AA395DCQ36066025-F503169F-C304-42FE-A027-9FE509D79461Q36178395-D2A0AE82-2061-4A71-A325-C41E13DB31F2Q36244207-7930DE06-463E-46B1-B09F-EFC8435C999AQ36321975-B3D813B2-DBD9-4C96-9919-90EA0D5926DBQ36429579-225AAFF5-140E-4588-8334-9141C0DB6FC9Q36485826-57A8DE05-F8D2-407E-A85F-0F88BA4F7725Q36581678-4734840C-18D6-4DF4-BDF0-A116976C28D4Q36615018-08D653D8-17E6-4620-B057-FD38C03856BAQ36616126-3071C6FE-EFD7-48B2-BA1F-1808D32FDAFEQ36623091-81DF541D-624B-4198-B8B3-F6B05DC08A9AQ36688779-C5719F87-D3C1-483B-9E18-505DD1A43CBBQ36705459-F5B05D00-6B45-4205-BA7E-E82FD70475B2Q36726235-A66E93B3-7EF8-4FCD-B5BD-6F962FFAA8A6Q36848899-E1055E22-02DE-4FF3-A6B4-AA0FD49AD875Q36897655-751654EC-936C-4307-A4C0-21AD216128DEQ36940193-175DDCD9-3615-4B2E-842D-54C6902D58B6Q36972087-6AAAAFD7-79F9-4BFB-8BDD-9312B45DEB91Q36977717-5263B337-A80D-4181-B27F-C5039F610AC1Q37093295-D9207913-409C-4F7B-A704-FA59018877F9Q37326557-A00FEA35-575C-4DBC-9014-569D246BBAC0Q37479033-775BBE21-C866-4603-8836-26669AD58E8F
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Defective E-cadherin/catenin complexes in human cancer.
@ast
Defective E-cadherin/catenin complexes in human cancer.
@en
Defective E-cadherin/catenin complexes in human cancer.
@nl
type
label
Defective E-cadherin/catenin complexes in human cancer.
@ast
Defective E-cadherin/catenin complexes in human cancer.
@en
Defective E-cadherin/catenin complexes in human cancer.
@nl
prefLabel
Defective E-cadherin/catenin complexes in human cancer.
@ast
Defective E-cadherin/catenin complexes in human cancer.
@en
Defective E-cadherin/catenin complexes in human cancer.
@nl
P2093
P356
P1433
P1476
Defective E-cadherin/catenin complexes in human cancer.
@en
P2093
Correia da Rocha AS
De Wever O
Van Aken E
P2888
P304
P356
10.1007/S004280100516
P577
2001-12-01T00:00:00Z